Scientists have made a discovery that could potentially lead to a way to "switch off" cancer genes. The finding involves a genetic or epigenetic approach, possibly using peptides or targeting a specific dna shape, although the details and potential applications are not entirely clear. The discovery may have implications for the treatment of various types of cancer, including pancreatic cancer, and could potentially lead to new immunotherapy drugs.